Michael Atkins
Fortune : 6 489 $ au 31/05/2026
Fortune : 6 489 $ au 31/05/2026
Michael B. Atkins currently holds the positions of Director at Melanoma Research Foundation, Independent Director at Werewolf Therapeutics, Inc. since 2024, President at Society For Immunotherapy of Cancer, and Professor at Harvard Medical School since 2002.
Dr. Atkins completed undergraduate education at Tufts University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2025 | 14 419 ( 0,03% ) | 6 489 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/01/2024 |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Directeur/Membre du Conseil | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Commercial Services |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national